Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Merck achieves milestone using Transgene technology

July 26, 2005

Oral low-dose interferon alpha to be studied for Behcet's disease

July 25, 2005

New phase II trial for Imvamune in HIV patients

July 22, 2005

Approvable letter for Pulminiq

July 20, 2005

Immunosuppressive action of 4OH-OPB

July 18, 2005

Rapid enrollment in ragweed allergy study of AIC

July 14, 2005

Immunomodulators claimed in recent patents

July 13, 2005

Tacrolimus ointment evaluated in allergic diseases

July 12, 2005

GenPat77 discovers novel protein that regulates immune cell activation

July 4, 2005

FDA accepts for review two Merck vaccine BLAs

July 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....